Cite
Bibert S, Guex N, Lourenco J, et al. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol. 2021;12:666163doi: 10.3389/fimmu.2021.666163.
Bibert, S., Guex, N., Lourenco, J., Brahier, T., Papadimitriou-Olivgeris, M., Damonti, L., Manuel, O., Liechti, R., Götz, L., Tschopp, J., Quinodoz, M., Vollenweider, P., Pagani, J. L., Oddo, M., Hügli, O., Lamoth, F., Erard, V., Voide, C., Delorenzi, M., Rufer, N., Candotti, F., Rivolta, C., Boillat-Blanco, N., Bochud, P. Y. (2021). Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Frontiers in immunology, 12666163. https://doi.org/10.3389/fimmu.2021.666163
Bibert, Stéphanie, et al. "Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients." Frontiers in immunology vol. 12 (2021): 666163. doi: https://doi.org/10.3389/fimmu.2021.666163
Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol. 2021 May 31;12:666163. doi: 10.3389/fimmu.2021.666163. eCollection 2021. PMID: 34135895; PMCID: PMC8202013.
Copy
Download .nbib